The global HLA Typing for Transplant Market was valued at USD 667.8 Million in 2021 and it is anticipated to grow up to USD 1189.6 Million by 2031, at a CAGR of 5.9% during the forecast period.
HLA typing is a laboratory test that is performed on a sample of a persons blood in order to determine their human leukocyte antigen (HLA) type. This information is used to match individuals with a compatible donor for bone marrow or stem cell transplants. HLA typing is performed using a technique called DNA sequencing. This involves taking a sample of blood and extracting the DNA. The DNA is then analyzed to identify the specific sequence of nucleotides (the building blocks of DNA) that make up the persons HLA type.
Get Access to A Free Sample Copy of Our Latest Report – https://www.globalinsightservices.com/request-sample/GIS24330
Market Trends and Drivers
Technological advancements in molecular assays segment are driving the global HLA Typing for transplant market progression. Presently, target specific PCR method is used to screen disease causative pathogen. Also, companies are focusing on development of novel platforms for HLA typing.
Major Players in the Global HLA Typing for Transplant Market
The key players in the market Abbott, Bio-Rad Laboratories, CareDx, Qiagen N.V., Thermo Fischer Scientific, F. Hoffmann-La Roche Ltd, Illumina Inc., Luminex Corporation and Immucor, Inc, Hologic, Inc., Luminex, and Biofortuna, among others.
COVID-19 Impact
The spread of COVID-19 pandemic across the globe had a minimal impact on market in 2020. Various companies registered a slowdown in testing service volumes in the final weeks of March and during April 2020 as well as faced significant challenges in exporting the products. This can be credited to increasing number of COVID-19 infections along with restrictions, delaying or postponing of the non-essential surgical including organ transplant and non-invasive procedures. These procedures are not considered as critical or life-saving procedure and hence, come under elective surgical procedures. Healthcare organizations were performing more out-patient elective surgical procedures, as countries and states begin to ease few COVID-19 restrictions. However, securing slots for bone marrow harvest makes extremely difficult for lab technicians and hospitals, as health care organizations have a backlog of surgeries. This provision of suboptimal supervision may hinder HLA typing for transplant to some extent during the forecast timeframe.
Get Customized Report as Per Your Requirement – https://www.globalinsightservices.com/request-customization/GIS24330
Global HLA Typing for Transplant Market Segmentation
By Technology
- Non-molecular assays
- Molecular assays
By Product & Services
- Instruments
- Reagents and consumables
- Software
- Services
By Application
- Diagnostics
- Research
By End-use
- Hospitals
- Diagnostic labs
- Academic and research institutes
Buy Now – https://www.globalinsightservices.com/checkout/single_user/GIS24330
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario
New Report Published by Global Insight Services: https://www.globalinsightservices.com/reports/hydrogen-projects-database/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1–833–761–1700
Website: https://www.globalinsightservices.com/